National Investment Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,361
Closed -$1.11M 14
2019
Q3
$1.11M Sell
8,361
-328
-4% -$44K 1.29% 30
2019
Q2
$1.23M Sell
8,689
-6,873
-44% -$932K 1.42% 30
2019
Q1
$2.26M Sell
15,562
-16
-0.1% -$2.1K 2.48% 11
2018
Q4
$1.76M Sell
15,578
-565
-3% -$70.7K 2.05% 14
2018
Q3
$2.17M Buy
16,143
+11,358
+237% +$1.4M 2.13% 15
2018
Q2
$537K Buy
+4,785
New +$517K 0.5% 61

Other funds holding CRL

National Investment Services's CRL Position: Q4 2019 in Review

National Investment Services sold out of Charles River Laboratories (CRL) in Q4 2019, closing a stake of 8,361 shares — an estimated $1.11M sold.

National Investment Services first reported a position in CRL in Q2 2018 and held it in 6 quarters. The position peaked at $2.26M in Q1 2019. 413 funds tracked by Wall St. Rank hold CRL as of Q4 2019.

  • National Investment Services reported no remaining Charles River Laboratories position as of Q4 2019 after selling out during the quarter.
  • National Investment Services sold 8,361 Charles River Laboratories shares in Q4 2019, an estimated $1.11M.
  • National Investment Services first reported a position in Charles River Laboratories in Q2 2018 and held it in 6 quarters.
  • National Investment Services's Charles River Laboratories position peaked at $2.26M in Q1 2019.
  • 413 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2019.

Based on National Investment Services's 13F filing for Q4 2019.